JP Morgan Maintains Overweight on Stryker, Lowers Price Target to $400

Benzinga Newsdesk www.benzinga.com Negative 85.9%

Neg 85.9% Neu 0% Pos 0%

JP Morgan analyst Robbie Marcus maintains Stryker (NYSE:SYK) with a Overweight and lowers the price target from $445 to $400.